Search Results

Displaying Results 6426-6450 of 11053 "'T'"

Mar 11, 2026, 04:00 ET BitGo invests in Ubyx and joins as a settlement agent to accelerate institutional digital asset infrastructure

integrity. By joining as a settlement agent and investor, BitGo B&T is supporting the infrastructure necessary for digital assets to scale globally within regulated frameworks."Tony McLaughlin, CEO of Ubyx, said: "BitGo B&T brings deep institutional custody expertise and regulatory credibility

More news about: Ubyx Inc.


Mar 10, 2026, 20:58 ET La demande de cours d'été internationaux est en forte hausse alors que le prestataire de services éducatifs d'Oxford se classe parmi les entreprises européennes à la croissance la plus rapide

rassemblons des étudiants talentueux originaires de plus de 175 pays pour qu'ils étudient dans certaines des universités les plus prestigieuses du monde », a-t-il déclaré. « Cette reconnaissance reflète le dévouement de notre équipe et la confiance que nous accordent les familles du monde entier, qui reconnaissent

More news about: Oxford Royale


Mar 10, 2026, 20:39 ET Blueprint Capital Advisors Announces the 2026 Power100 Allocators Honorees

HealthMarcus Alexis, IndependentCheryl Alston, Parkwood EntertainmentBrian Andre, Children's Hospital of Philadelphia (CHOP)Brad T. Atkins, Franklin Park AssociatesSam Austin, New England Pension Consultants (NEPC)Taffi Ayodele, Office of the New York City ComptrollerJagdeep

More news about: Blueprint Capital Advisors


Mar 10, 2026, 20:02 ET EBITDA CRESCE 7,5% COM MARGEM RECORDE DE 79%

eficiência, fizeram o EBITDA do 4T25 atingir R$ 672,0 milhões, alta de 7,5% sobre o 4T24. Margem EBITDA alcançou 79,0%, um avanço de 192 bps comparado ao 4T24.VENDAS CRESCEM 5,1%: As vendas nos shoppings cresceram acima do varejo e, superam em 5,1% o 4T24.ALLOS ATINGE 20,9% DE MARKET

More news about: ALLOS S.A.


Mar 10, 2026, 17:31 ET CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight

growing pipeline of investigational drugs such as Obexelimab (Zenas BioPharma), GLPG5101 (Galapagos NV), IKS 03 (Iksuda Therapeutics), ANKTIVA + CD19 t-haNK (ImmunityBio), NKX019 (Nkarta), CABA-201 (Cabaletta Bio), CLN-978 (Cullinan Therapeutics), ATA3219 (Atara Bio), KITE-363, KITE-753, KITE-197, and

More news about: DelveInsight Business Research, LLP


Mar 10, 2026, 17:11 ET Franco-Nevada Reports Record 2025 Results

production front-loaded of approximately 800,000 gold ounces per year) supported by a maiden Merlin Mineral Reserve of 4.9 million ounces (88Mt @ 1.75g/t). AngloGold is continuing to drill to expand the resource and has outlined a pathway to 18 to 20 million ounces when including the Silicon Mineral Resource

More news about: Franco-Nevada Corporation


Mar 10, 2026, 16:05 ET Safehold Closes 20th Affordable Housing Ground Lease, First in Texas

Steve WylderHead of Investments T: 310.315.5566E: [email protected]

More news about: Safehold


Mar 10, 2026, 12:53 ET /C O R R E C T I O N -- Go!Foton/

More news about: Go!Foton


Mar 10, 2026, 12:48 ET S4 Capital's Monks Strengthens LatAm Leadership, Appointing Paula Marsilli to Drive Real-Time Strategy for Key Regional Accounts

clients don't just need people to manage hours; they need leaders who can orchestrate complex, AI-enabled systems. Paula is the definition of the 'T-shaped talent' we are prioritizing—someone who can bridge high-tech efficiency with high-touch human strategy. She brings the operational rigor we need to

More news about: Monks


Mar 10, 2026, 11:00 ET OPPO Reno14 F 5G se consolida como uno de los smartphones más populares del mercado y está disponible en AT&T México

posibilidades. Los productos y servicios de AT&T México están disponibles a nivel nacional en sus puntos de venta. Más información en att.com.mx. ©2026 AT&T Intellectual Property II, L.P., AT&T y el logotipo del Globo son marcas

More news about: OPPO Mexico


Mar 10, 2026, 10:00 ET FORMULATED MATERIALS LAUNCHES THE INTEGRATED™ RAILING SYSTEM FOR BALCONY CONSTRUCTION

portfolio enables our partners to deliver a more fully integrated system while streamlining a common scope on multifamily projects."T-Bar. Embed Pans. Double Drip T-Bar. Drainage Mat. Integrated™ Railing. Together, they create a seamless approach to building durable balcony assemblies from the structure

More news about: Formulated Materials


Mar 10, 2026, 10:00 ET Cold as Ice: Dodge Adds New Sub-Zero Paint to Charger Lineup

McAlear, Dodge CEO. "Sub-Zero is the next in line of options available for the entire Charger lineup, from the 420-horsepower SIXPACK-powered Charger R/T and the 550-horsepower SIXPACK-powered Scat Pack to the 670-horsepower

More news about: Stellantis


Mar 10, 2026, 09:00 ET Investment in U.S.-Based Fusion Company SHINE Technologies

areas where commercialization is advancing, particularly in the expansion of medical isotopes and neutron sources generated through deuterium-tritium (D-T) fusion reactions, with a particular focus on Asian markets. The investment strengthens this collaboration by transitioning the relationship from an

More news about: Sumitomo Corporation of Americas


Mar 10, 2026, 08:55 ET NYSE Content Update: AT&T CEO John Stankey to Ring Bell on 150th Anniversary of First Phone Call

activist Gloria Steinem, celebrated International Women's Day at the NYSE on Monday, March 9, by ringing the Closing Bell.Telecom giant AT&T (NYSE: T) announces a $250 billion commitment to advance U.S. connectivity as it marks the 150th anniversary of the first telephone call.Nexthop

More news about: New York Stock Exchange


Mar 10, 2026, 08:47 ET Citius Oncology Announces Positive Topline Results from Investigator‑Initiated Phase 1 Study of LYMPHIR™ in Combination with Pembrolizumab in Relapsed or Refractory Gynecologic Cancers

depletion of regulatory T‑cells may enhance anti‑tumor immune responses and help overcome immunotherapy resistance in these difficult‑to‑treat tumors.About LYMPHIR™ (denileukin diftitox‑cxdl)LYMPHIR is a targeted immune therapy for relapsed or refractory cutaneous T-cell lymphoma (CTCL)

More news about: Citius Oncology, Inc.


Mar 10, 2026, 08:45 ET Follett Software Brings AI-Powered Intelligence to IT Asset Manager, Giving K-12 Technology Teams a Smarter Command Center Before the Next School Year

comprehensive solutions for library, curriculum, IT, and facilities management – all in one platform. Named to the GSV 150 and recognized by EdTech Digest and T&L ISTE Best of Show, Follett Software's award-winning platform provides real-time insights and productivity tools that save time, reduce costs, and support

More news about: Follett Software


Mar 10, 2026, 08:30 ET IBI Ag Announces Successful Development of AI-Driven De Novo Protein Design Platform for Bioinsecticides

provides a new mode of action for controlling a broad range of insect pests with minimal ecological footprint. Founded by The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), together with Prof. Amir Ayali and Dr. Rony Oren Benaroya, and supported by the Israel Innovation Authority, IBI Ag is redefining the

More news about: IBI Ag


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.